Kalp cerrahisi hemşirelerinin warfarine ilişkin bilgileri: eğitim etkinliğinin değerlendirilmesi

Abstract

Amaç: Bu çalışmanın amacı, kalp cerrahisi hemşirelerine warfarin kullanımına ilişkin verilen eğitimin etkinliğinin değerlendirilmesidir. Yöntemler: Ön test-son test yarı deneysel tipte olan bu çalışma, Haziran ve Temmuz 2025 tarihleri arasında bir üniversite hastanesinin Kalp ve Damar Cerrahisi Anabilim Dalı’nda yürütülmüştür. Çalışmanın örneklemini klinik ve yoğun bakım ünitesinde çalışan, çalışmaya katılmaya gönüllü olan 30 hemşire oluşturmuştur. Araştırma kapsamında hemşirelere warfarin kullanımı konusunda eğitim verilmiş olup hemşirelerin bilgileri eğitim öncesi ve sonrası ölçülerek eğitimin etkinliği değerlendirilmiştir. Bulgular: Araştırmaya katılan hemşirelerin yaş ortalaması 33.30±6.62 yıldır. Hemşirelerin eğitim öncesi warfarin kullanımına ilişkin bilgi puanı ortalaması 15.00±2.74 iken eğitim sonrası 18.03±1.29’a yükselmiştir. Hemşirelerin eğitim öncesi warfarin-ilaç etkileşimleri ile ilgili bilgi puan ortalaması 13.40±14.40’tan 41.80±10.43’e ve warfarin-besin-bitki etkileşimleri ile ilgili bilgi puan ortalaması da 9.73±5.51’den 24.60±11.05’e yükselmiştir. Sonuç: Bu çalışmada, kalp cerrahisi hemşirelerinin warfarin kullanımına ilişkin bilgilerinin orta düzeyin üzerinde, ilaç, besin-bitki etkileşimlerine yönelik bilgilerinin yetersiz düzeyde olduğu; eğitim sonrası ise bilgi düzeylerinde belirgin artış sağlandığı saptanmıştır.

Keywords

• eğitim
• kalp cerrahisi hemşireleri
• warfarin

Cardiac surgery nurses' knowledge of warfarin: evaluation of a training activity

Abstract

Aims: The aim of this study is to evaluate the effectiveness of the training provided to cardiac surgery nurses regarding warfarin use. Methods: This pre-test-post-test quasi-experimental study was conducted between June and July 2025 at the department of cardiovascular surgery of a university hospital. The sample consisted of 30 nurses working in the clinic and intensive care unit who volunteered to participate in the study. As part of the research, nurses were educated on warfarin use, and their knowledge was measured before and after the training to evaluate the effectiveness of the training. Data were analysed using SPSS 25.0. Descriptive statistics were calculated, and pre- and post-test scores were compared using the Wilcoxon signed-rank test. Results: The average age of the nurses participating in the study was 33.30±6.62 years. The average pre-training knowledge score of nurses regarding warfarin use was 15.00±2.74, while the post-training score increased to 18.03±1.29. The average knowledge score of nurses regarding warfarin-drug interactions before training was 13.40±14.40, while after training it was 41.80±10.43, and the average knowledge score regarding warfarin-food-herb interactions increased from 9.73±5.51 to 24.60±11.05. According to the Wilcoxon signed-rank test results, statistically significant increases were observed in nurses’ knowledge scores regarding warfarin use and, warfarin–drug interactions, and warfarin–food–herb interactions after the training (p<0.001). The large effect sizes indicate that the training had a strong impact across all knowledge domains. Conclusion: This study found that cardiac surgery nurses had a sufficient level of knowledge regarding warfarin use but insufficient knowledge about drug, food and herb interactions; however, the educational intervention led to statistically significant improvements with large effect sizes across all knowledge domains.

Keywords

• Cardiovascular nursing
• education
• nursing
• warfarin

References

1. Ehsani M, Farahani MA, Haghani S, Khaleghparast S, Memar MM. Assessment of knowledge and practice of cardiovascular nurses regarding warfarin. J Educ Health Promot. 2022;11:270. doi:10.4103/jehp.jehp_1240_21
2. Chang S, Lombardo A, Smith I, Lawler S, He C, Stroebel A. Early use of non-vitamin K antagonist oral anticoagulants after cardiac surgery compared with warfarin for postoperative atrial fibrillation. ANZ J Surg. 2025;95(6):1135-1141. doi:10.1111/ans.70045
3. Schloeglhofer T, Marschuetz A, Combs P, et al. Quality of anticoagulation with phenprocoumon and warfarin in left ventricular assist device patients: a multicenter study. ASAIO J. 2023;69(6):595-601. doi:10.1097/MAT.0000000000001895
4. Zhu Z, Li C, Shen J, et al. New internet-based warfarin anticoagulation management approach after mechanical heart valve replacement: prospective, multicenter, randomized controlled trial. J Med Internet Res. 2021;23(8):e29529. doi:10.2196/29529
5. Ge B, Zhang Z, Zuo Z. Updates on the clinical evidenced herb-warfarin interactions. Evid Based Complement Alternat Med. 2014;2014:957362. doi:10.1155/2014/957362
6. Osuala EC, Ojewole EB. Knowledge, attitudes and practices of healthcare professionals regarding drug–food interactions: a scoping review. Int J Pharm Pract. 2021;29(5):406-415. doi:10.1093/ijpp/riab049
7. Li SL, Zhou SH, Lin YJ. The value of continuous nursing in patients after cardiac mechanical valve replacement. J Cardiothorac Surg. 2020;15(1): 299. doi:10.1186/s13019-020-01326-5
8. Zandi S, Imani B, Gholamreza S. Self-care training and informational support of patients with a mechanical heart valve on the international normalized ratio and bleeding complications. Kardichir Torakochirurgis Pol. 2021;18(2):80-86. doi:10.5114/kitp.2021.107468

9. Couris RR, Tataronis GR, Dallal GE, Blumberg JB, Dwyer JT. Assessment of healthcare professionals’ knowledge about warfarin-vitamin K drug-nutrient interactions. J Am Coll Nutr. 2000;19(4):439-445. doi:10.1080/07315724.2000.10718944
10. Eltheni R, Schizas N, Michopanou N, Fildissis G. Effects of a personalized nurse-led educational program for new patients receiving oral anticoagulant therapy after mechanical heart valve prosthesis implantation on adherence to treatment. J Chest Surg. 2021;54(1):25. doi: 10.5090/kjtcs.20.106
11. Khan RA, Shah BA, Noreen N, Khan RA, Ghani N. Effect of health education on knowledge regarding post-operative care among patients with mechanical valve replacement: a quasi-experimental study. Asian J Res Nurs Health. 2020;3(1):33-41. doi:10.9734/AJRNH/2020/v3i130045
12. Cao H, Wu T, Chen W, Fu J, Xia X, Zhang J. The effect of warfarin knowledge on anticoagulation control among patients with heart valve replacement. Int J Clin Pharm. 2020;42(3):861-870. doi:10.1007/s11096-020-01043-y
13. Van Damme S, Van Deyk K, Budts W, Verhamme P, Moons P. Patient knowledge of and adherence to oral anticoagulation therapy after mechanical heart-valve replacement for congenital or acquired valve defects. Heart Lung. 2011; 40(2):139-146. doi:10.1016/j.hrtlng.2009.11.005
14. Al-Arifi MN, Wajid S, Al-Manie NK, et al. Evaluation of knowledge of health care professionals on warfarin interactions with drug and herb medicinal in Central Saudi Arabia. Pak J Med Sci. 2016;32(1):229. doi:10. 12669/pjms.321.8902
15. Baysal E, Ergin E, Pakyüz SÇ. Does in-service training affect to nurses’ knowledge level about the anticoagulant drugs? J Hum Sci. 2016;13(3): 4725-4437. doi:10.14687/jhs.v13i3.3970
16. Oterhals K, Deaton C, De Geest S, et al. European cardiac nurses’ current practice and knowledge on anticoagulation therapy. Eur J Cardiovasc Nurs. 2014;13(3):261-269. doi:10.1177/1474515113491658
17. Türk Kardiyoloji Derneği (TKD). Turkish Cardiology Society (TCS). 2020. Accessed October 9, 2025. https://file.tkd.org.tr/kilavuzlar/Kilavuz- 202002171723028.pdf?menu=190
18. Moster M, Bolliger D. Perioperative guidelines on antiplatelet and anticoagulant agents: 2022 update. Curr Anesthesiol Rep. 2022;12(2):286-296. doi:10.1007/s40140-022-00502-8
19. Garrison SR, Green L, Kolber MR, et al. The effect of warfarin administration time on anticoagulation stability (INRange): a pragmatic randomized controlled trial. Ann Fam Med. 2020;18(1):42-49. doi:10.1370/afm.2488
20. Martins MA, Carlos PP, Ribeiro DD, et al. Warfarin drug interactions: a comparative evaluation of the lists provided by five information sources. Eur J Clin Pharmacol. 2011;67:1301-1308. doi:10.1007/s00228-011-1086-4
21. Hines LE, Ceron-Cabrera D, Romero K, et al. Evaluation of warfarin drug interaction listings in US product information for warfarin and interacting drugs. Clin Ther. 2011;33(1):36-45. doi:10.1016/j.clinthera. 2011.01.021
22. Booth SL, Pennington JA, Sadowski JA. Food sources and dietary intakes of vitamin K-1 (Phylloquinone) in the American diet: data from the PDA Total Diet Study. J Am Diet Assoc. 1996;96(2):149-154. doi:10. 1016/s0002-8223(96)00044-2
23. Tan CSS, Lee SWH. Warfarin and food, herbal or dietary supplement interactions: a systematic review. Br J Clin Pharmacol. 2021;87(2):352-374. doi:10.1111/bcp.14404
24. Norcini JJ. Setting standards on educational tests. Med Educ. 2003;37(5): 464-469. doi:10.1046/j.1365-2923.2003.01495.x
25. Chen A, Stecker E, Warden BA. Direct oral anticoagulant use: a practical guide to common clinical challenges. J Am Heart Assoc. 2020;9(13): e017559. doi:10.1161/JAHA.120.017559
26. Vranckx P, Valgimigli M, Heidbuchel H. The significance of drug–drug and drug–food interactions of oral anticoagulation. Arrhythm Electrophysiol Rev. 2018;7(1):55. doi:10.15420/aer.2017.50.1
27. Subih M, Rababa M, Aryan FS, et al. Factors influencing nurses’ knowledge and competence in warfarin-drug and nutrient interactions and patient counseling practices. BMC Med Educ. 2025;25(1):540. doi: 10.1186/s12909-025-07074-1
28. Counterman ED, Lawley SD. What should patients do if they miss a dose of medication? A theoretical approach. J Pharmacokinet Pharmacodyn. 2021;48(6):873-892. doi:10.1007/s10928-021-09777-6
29. Xue L, Ma G, Holford N, et al. A randomized trial comparing standard of care to Bayesian warfarin dose individualization. Clin Pharmacol Ther. 2024;115(6):1316-1325. doi:10.1002/cpt.3207
30. Franco V, Polanczyk CA, Clausell N, Rohde LE. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. Am J Med. 2004;116(10):651-656. doi:10.1016/j.amjmed.2003.12.036
31. Talasaz AH, McGonagle B, HajiQasemi M, et al. Pharmacokinetic and pharmacodynamic interactions between food or herbal products and oral anticoagulants: evidence review, practical recommendations, and knowledge gaps. Semin Thromb Hemost. 2025;51(5):560-571. doi:10. 1055/s-0044-1790258
32. Yarrington CD, Valente AM, Economy KE. Cardiovascular management in pregnancy: antithrombotic agents and antiplatelet agents. Circulation. 2015;132(14):1354-1364. doi:10.1161/CIRCULATIONAHA.114.003902
33. Zaidi SR, Jenkins S. Anticoagulant therapy in pregnancy. StatPearls. 2024.
34. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: executive summary. Circulation. 2014;129(23):2440-2492. doi:10.1161/CIR.0000000000000029
35. Mahé I, Bertrand N, Drouet L, et al. Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study. Haematologica. 2006;91(12):1621-1627. doi:10.3324/haematol.10142
36. Kalhor HR, Taghikhani E. Probe into the molecular mechanism of ibuprofen interaction with warfarin bound to human serum albumin in comparison to ascorbic and salicylic acids: allosteric inhibition of anticoagulant release. J Chem Inf Model. 2021;61(8):4045-4057. doi:10. 1021/acs.jcim.1c00352
37. Geng J, Qian J, Cheng H, Ji F, Liu H. The influence of perioperative dexmedetomidine on patients undergoing cardiac surgery: a meta-analysis. PLoS One. 2016;11(4):e0152829. doi:10.1371/journal.pone. 0152829
38. Huang X, Du P, Jia H, et al. Methodologic quality and pharmacotherapy recommendations for patient blood management guidelines for cardiac surgery on cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2024; 38(7):1569-1576. doi:10.1053/j.jvca.2024.03.011
39. Leite PM, Martins MAP, das Graças Carvalho M, Castilho RO. Mechanisms and interactions in concomitant use of herbs and warfarin therapy: an updated review. Biomed Pharmacother. 2021;143:112103. doi:10.1016/j.biopha.2021.112103
40. Roth JA, Bradley K, Thummel KE, Veenstra DL, Boudreau D. Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting. Pharmacoepidemiol Drug Saf. 2015;24(6):619-627. doi:10.1002/pds.3769
41. Sonuga BO, Hellenberg DA, Cupido CS, Jaeger C. Profile and anticoagulation outcomes of patients on warfarin therapy in an urban hospital in Cape Town, South Africa. Afr J Prim Health Care Fam Med. 2016;8(1):1-8. doi:10.4102/phcfm.v8i1.1032